http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-054780-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
filingDate 2006-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4ab8ef6da84e7d3686c1a7bc2d35e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d76a1e92a25a9520cc083788e35a391a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5937fe7b5450bd966aa78901e675f233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bba2e9941bf1861b980e88ca2cd936d6
publicationDate 2007-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-054780-A1
titleOfInvention STEROIDS THAT HAVE A MIXED PROFILE OF ANDROGENIC AND PROGESTAGENIC EFFECTS
abstract Compounds of formula (1), wherein R1 is O, (H, H), (H, OH) or NOR, where R is hydrogen, C1-6 alkyl or C1-6 acyl; R2 is hydrogen, methyl, ethyl or ethenyl; R3 is hydrogen, methyl, ethyl, ethenyl, fluorine or chlorine; R4 is methyl or ethyl; R5 is hydrogen, methyl or ethyl; R6 is hydrogen, methyl, ethyl, C2-3 alkenyl or C2-3 alkynyl; R7 is hydrogen or C1-15 acyl and at least one of R5 or R6 is hydrogen; or a pharmaceutically acceptable salt thereof, for use as a medicament for a treatment to increase androgen levels, for androgen supplementation, for testosterone replacement and for benign prostatic hypertrophy, and a method of male contraception, preferably as a unique means to achieve a progestagenic sterilizing effect and also androgen supplementation.
priorityDate 2005-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705

Total number of triples: 42.